WASHINGTON - The Senate will wait more than two weeks before acting on a bill to permanently fix the flawed formula for reimbursing Medicare physicians, after an April 1 deadline to start a 21 percent cut in payment rates.
LONDON - A 25-year-old British military nurse who was the first person in the world to be treated for Ebola with the experimental drug MIL 77 was discharged from hospital on Friday, London's Royal Free Hospital said.
(Reuters Health) – - Mothers who are overweight before pregnancy and those who gain too much while pregnant are more likely to have obese seven-year-olds, researchers say.
(Reuters Health) - Thanks to a generous benefactor, young mothers doing laboratory research at the Massachusetts General Hospital in Boston can receive major grants to keep them from falling behind while they raise their children.
(Reuters Health) – - Eyeliner applied on the inside of the lash line is very likely to move into the eye itself and cause symptoms, according to a small study that captured migrating makeup on video.
PARIS - French drugmaker Sanofi plans to launch its new Toujeo insulin for diabetics in the United States on Monday, according to a source familiar with the matter.
- Denmark's Novo Nordisk is to resubmit its new insulin Tresiba to U.S. regulators based on interim analysis data from a clinical trial, bringing its biggest new drug hope closer to the world's top market.
LONDON - European regulators have postponed a decision on whether to recommend approval of a closely watched Bristol-Myers Squibb drug that helps the immune system fight cancer, officials said on Friday.
FREETOWN - The capital of Sierra Leone was "eerily quiet" on Friday at the start of a three-day national lockdown aimed at accelerating the end of an Ebola epidemic in the worst affected country.
- Ohr Pharmaceutical Inc said its experimental eye drug failed the main goal in a mid-stage study as a combination therapy, wiping out two-thirds of the company's market value on Friday.